Mapping the Human Herpesvirus 6B transcriptome.


Journal

Journal of virology
ISSN: 1098-5514
Titre abrégé: J Virol
Pays: United States
ID NLM: 0113724

Informations de publication

Date de publication:
26 04 2021
Historique:
entrez: 25 2 2021
pubmed: 26 2 2021
medline: 26 2 2021
Statut: ppublish

Résumé

The "omics" revolution of recent years has simplified the study of RNA transcripts produced during viral infection and under specific defined conditions. In the quest to find new and differentially expressed transcripts during the course of human Herpesvirus 6B (HHV-6B) infection, we made use of large-scale RNA sequencing to analyze the HHV-6B transcriptome during productive infection of human Molt-3 T-cells. Analyses were performed at different time points following infection and specific inhibitors were used to classify the kinetic class of each open reading frame (ORF) reported in the annotated genome of HHV-6B Z29 strain. The initial search focussed on HHV-6B-specific reads matching new HHV-6B transcripts. Differential expression of new HHV-6B transcripts were observed in all samples analyzed. The presence of many of these new HHV-6B transcripts were confirmed by RT-PCR and Sanger sequencing. Many of these transcripts represented new splice variants of previously reported ORFs, including some transcripts that have yet to be defined. Overall, our work demonstrates the diversity and the complexity of the HHV-6B transcriptome.

Identifiants

pubmed: 33627386
pii: JVI.01335-20
doi: 10.1128/JVI.01335-20
pmc: PMC8139660
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2021 Gravel et al.

Références

J Virol. 2018 Apr 27;92(10):
pubmed: 29491155
Virology. 1995 May 10;209(1):29-51
pubmed: 7747482
Nat Commun. 2020 Apr 27;11(1):2038
pubmed: 32341360
Curr Opin Virol. 2014 Dec;9:111-8
pubmed: 25462442
J Virol. 2019 Dec 12;94(1):
pubmed: 31597766
Science. 2012 Nov 23;338(6110):1088-93
pubmed: 23180859
Biol Blood Marrow Transplant. 2018 Nov;24(11):2324-2336
pubmed: 29684567
Front Microbiol. 2016 Jun 06;7:869
pubmed: 27375590
J Virol. 1997 Jun;71(6):4400-8
pubmed: 9151830
Nucleic Acids Res. 2014 Apr;42(7):4640-51
pubmed: 24464992
J Virol. 2014 Jan;88(1):120-30
pubmed: 24131715
Expert Opin Ther Targets. 2013 Feb;17(2):157-66
pubmed: 23231449
Lancet. 1988 May 14;1(8594):1065-7
pubmed: 2896909
J Virol. 2007 Dec;81(24):13761-70
pubmed: 17928340
BMC Genomics. 2018 Mar 20;19(1):204
pubmed: 29554870
J Virol. 2011 Jan;85(1):378-89
pubmed: 20980502
Genome Announc. 2013 Jun 13;1(3):
pubmed: 23766398
J Virol. 2012 Feb;86(3):1638-49
pubmed: 22114334
J Gen Virol. 2009 Nov;90(Pt 11):2581-2591
pubmed: 19625464
Proc Natl Acad Sci U S A. 2015 Jun 30;112(26):8058-63
pubmed: 26080419
Proc Natl Acad Sci U S A. 2010 Mar 23;107(12):5563-8
pubmed: 20212114
Rev Med Virol. 2012 May;22(3):144-55
pubmed: 22052666
J Virol. 2010 May;84(9):4659-72
pubmed: 20181707
PLoS Pathog. 2020 Apr 22;16(4):e1008496
pubmed: 32320442
J Virol. 2019 Jan 17;93(3):
pubmed: 30429336
J Virol. 1999 Oct;73(10):8040-52
pubmed: 10482553
J Virol. 2002 Aug;76(15):7578-86
pubmed: 12097571
J Virol. 2010 Dec;84(23):12100-9
pubmed: 20844040
J Biol Chem. 2002 May 31;277(22):19679-87
pubmed: 11901159
J Virol. 2017 Jun 26;91(14):
pubmed: 28468878
Microbes Infect. 2011 Aug;13(8-9):731-41
pubmed: 21458587
Elife. 2020 Jan 16;9:
pubmed: 31944176
N Engl J Med. 1994 Aug 18;331(7):432-8
pubmed: 8035839
J Virol. 1999 Oct;73(10):8053-63
pubmed: 10482554

Auteurs

Annie Gravel (A)

Division of Infectious Disease and Immunity, CHU de Québec Research Center, Quebec City, Québec, Canada.

Wes Sanders (W)

Department of Microbiology and Immunology, UNC School of Medicine, Chapel Hill, North Carolina, USA.

Éric Fournier (É)

Division of Endocrinology and Nephrology, CHU de Québec Research Center, Quebec City, Québec, Canada.

Arnaud Droit (A)

Division of Endocrinology and Nephrology, CHU de Québec Research Center, Quebec City, Québec, Canada.

Nathaniel Moorman (N)

Department of Microbiology and Immunology, UNC School of Medicine, Chapel Hill, North Carolina, USA.

Louis Flamand (L)

Division of Infectious Disease and Immunity, CHU de Québec Research Center, Quebec City, Québec, Canada Louis.flamand@crchudequebec.ulaval.ca.
Department of Microbiology, Infectious Disease and Immunology, Faculty of Medicine, Université Laval, Quebec City, Québec, Canada.

Classifications MeSH